⭐Out today!
Read the phase I clinical trial on neoantigen DNA vaccine for patients with glioblastoma
www.nature.com/articles/s43...
Johanns and colleagues report the results (including safety, efficacy and immunogenicity) of a phase 1 clinical trial of a DNA-based personalized therapeutic cancer vaccine administered following surg...